Camp4 Therapeutics Stock (NASDAQ: CAMP) stock price, news, charts, stock research, profile.
You can purchase shares of Camp4 Therapeutics (NASDAQ:CAMP) through any online brokerage.
Other companies in Camp4 Therapeutics’s space includes: Invizyne Technologies (NASDAQ:IZTC), Anixa Biosciences (NASDAQ:ANIX), Skye Bioscience (NASDAQ:SKYE), Adverum Biotechnologies (NASDAQ:ADVM) and Inozyme Pharma (NASDAQ:INZY).
Camp4 Therapeutics has a consensus price target of $9.40.
The stock price for Camp4 Therapeutics (NASDAQ: CAMP) is $4.52 last updated January 17, 2025 at 9:30 AM EST.
There are no upcoming dividends for Camp4 Therapeutics.
Camp4 Therapeutics’s Q3 earnings are confirmed for Thursday, November 21, 2024.
There is no upcoming split for Camp4 Therapeutics.
Camp4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.